BRIEF-Trevi Therapeutics Announces Positive Topline Results From Its Phase 2a RIVER Trial Of Haduvio For Treatment Of Patients With RCC

Reuters
03-10
BRIEF-Trevi <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Positive Topline Results From Its Phase 2a RIVER Trial Of Haduvio For Treatment Of Patients With RCC

March 10 (Reuters) - Trevi Therapeutics Inc TRVI.O:

  • TREVI THERAPEUTICS INC: HADUVIO MET PRIMARY ENDPOINT

  • TREVI THERAPEUTICS: ANNOUNCE POSITIVE TOPLINE RESULTS FROM ITS PHASE 2A RIVER TRIAL OF HADUVIO FOR TREATMENT OF PATIENTS WITH RCC (N=66)

  • TREVI THERAPEUTICS: PATIENT REPORTED & OTHER SECONDARY OUTCOMES WERE STATISTICALLY SIGNIFICANT & CONSISTENT WITH PRIMARY ENDPOINT

Source text: ID:nPn7xKPQHa

Further company coverage: TRVI.O

((Reuters.Briefs@thomsonreuters.com;))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10